ValiRx plc announced that Adrian de Courcey will join the ValiRx Board as a proposed Non-Executive Director, subject to completion of regulatory due diligence and Ray Horn will become a Board observer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 GBX | -.--% | +2.43% | -50.00% |
May. 20 | London gets boost thanks to rate cut hopes | AN |
May. 20 | ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.00% | 4.97M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- VAL Stock
- News ValiRx plc
- Valirx plc Announces Board Appointments, Subject to Completion of Regulatory Due Diligence